Brookstone Capital Management Sells 5,538 Shares of The Clorox Company $CLX

Brookstone Capital Management trimmed its position in shares of The Clorox Company (NYSE:CLX) by 6.2% during the 1st quarter, HoldingsChannel.com reports. The firm owned 83,998 shares of the company’s stock after selling 5,538 shares during the period. Brookstone Capital Management’s holdings in Clorox were worth $8,705,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Vermillion & White Wealth Management Group LLC bought a new position in shares of Clorox in the third quarter worth approximately $25,000. Darwin Wealth Management LLC bought a new stake in shares of Clorox during the second quarter valued at approximately $29,000. Caitlin John LLC increased its position in shares of Clorox by 1,807.1% during the fourth quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after acquiring an additional 253 shares in the last quarter. Ameriflex Group Inc. raised its holdings in Clorox by 1,436.8% in the 3rd quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock worth $36,000 after acquiring an additional 273 shares during the last quarter. Finally, Vision Financial Markets LLC raised its holdings in Clorox by 166.7% in the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after acquiring an additional 200 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have commented on CLX shares. Zacks Research downgraded Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. BNP Paribas Exane decreased their price target on Clorox from $128.00 to $97.00 and set a “neutral” rating for the company in a research note on Tuesday, May 12th. JPMorgan Chase & Co. lowered their price target on Clorox from $99.00 to $95.00 and set an “underweight” rating on the stock in a report on Friday, May 1st. Citigroup lowered their price target on Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Finally, Morgan Stanley reduced their price objective on Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a report on Friday, May 1st. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Clorox currently has an average rating of “Reduce” and a consensus target price of $103.40.

Clorox Stock Down 5.4%

Shares of Clorox stock opened at $90.61 on Tuesday. The Clorox Company has a twelve month low of $84.70 and a twelve month high of $132.03. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The company’s 50 day moving average is $95.37 and its 200 day moving average is $104.70. The company has a market cap of $10.96 billion, a price-to-earnings ratio of 14.71, a price-to-earnings-growth ratio of 0.50 and a beta of 0.56.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm’s revenue was up .1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Research analysts anticipate that The Clorox Company will post 5.61 EPS for the current year.

Insider Activity

In other news, Director Pierre R. Breber acquired 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The stock was bought at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the acquisition, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. The trade was a 38.46% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.63% of the stock is currently owned by company insiders.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.